AzTrials
AzTrials

Occupational TherapyNCT06871566

AI-Supported Occupational Therapy for Handwriting

A study testing Artificial Intelligence-Supported Occupational Therapy Program in people with Occupational Therapy, run by Hacettepe University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim: This study investigates the impact of an AI-supported occupational therapy program, developed using the Model of Human Occupation (MOHO), on handwriting skills in children at risk for Developmental Coordination Disorder (DCD). Read more about this study

Who is it for?
Ages 8 to 12 years
Conditions the study is for
Occupational Therapy
What is being tested?
Artificial Intelligence-Supported Occupational Therapy Program
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 siteTurkey (Türkiye)
Study dates
12 Apr 2024to 30 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • being between the ages of 8-12 years
  • being at risk for DCD according to the Developmental Coordination Disorder Questionnaire (DCDQ)
  • having the ability to understand the questionnaires
  • continuing formal education
  • having similar motor skill performance (having similar results from the Bruininks-Oseretsky Motor Proficiency Test 2 Brief Form (BOT2-BF)) and having similar visual perception level (having similar results from the Motor-Free Visual Perception Test-3(MVPT-3)

Who cannot join

  • having another neurodevelopmental, orthopedic and chronic problem (2) continuing any rehabilitation program
  • -

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Güleser Güney Yılmaz

    Ankara, 06800

Other trials in Turkey (Türkiye)

About this study

Official title: Artificial Intelligence-Supported Occupational Therapy Program on Handwriting Skills in Children at Risk for Developmental Coordination Disorder: Randomized Controlled Trial

Aim: This study investigates the impact of an AI-supported occupational therapy program, developed using the Model of Human Occupation (MOHO), on handwriting skills in children at risk for Developmental Coordination Disorder (DCD).

Method: A randomized controlled trial was conducted with 42 children aged 8-12 years, identified as being at risk for DCD using the Developmental Coordination Disorder Questionnaire (DCDQ). Participants were randomized into an intervention group (n=21) and a control group (n=21). The intervention group received an AI-supported occupational therapy program twice weekly for 8 weeks. Handwriting performance was assessed pre- and post-intervention using the Minnesota Handwriting Assessment (MHA).

Keywords: artificial intelligence, occupational

Being tested
Artificial Intelligence-Supported Occupational Therapy Program
Keywords
Artifical intellegence, occupational therapy, developmental coordination disorders, handwriting, rehabilitation
Medical subject headings
Motor Skills Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Artificial Intelligence-Supported Occupational Therapy ProgramOther

    The AI-supported occupational therapy program was individually implemented by an occupational therapist over 8 weeks, with 2 sessions per week, each lasting 45 minutes. A touchscreen tablet, touch pen, and external camera were utilized during the sessions. At the beginning of the program, technological devices and artificial intelligence tools were introduced to the children. For the goals and detailed intervention program of the 8-week schedule

Study groups in NCT06871566
Study groupRoleWhat they receive
Study groupExperimentalChildren at Risk for Developmental Coordination Disorder
Receives: Other: Artificial Intelligence-Supported Occupational Therapy Program
Control groupNo interventionChildren at Risk for Developmental Coordination Disorder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Minnesota Handwriting Assessment

    (MHA) assesses six categories of handwriting, including legibility, form, alignment, size, spacing and writing speed. The MHA consists of words that include all letters of the Turkish alphabet at least once and consist of 34 letters in total, and can be understood by children at the primary school level 23. In the test application, children copy this word sequence written on the paper to the marked line immediately below. In the scoring phase, the length of 1/16 inch (0.15 cm) is taken as a basis and all deviations, proportions between letters and within letters are evaluated by measuring this length with a ruler. The lowest score in each category of the MHA is 0 and the highest score is 34 24.

    Measured: Two assessments, one week before the intervention and one week after the intervention was completed

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2025
  2. Study start12 Apr 2024
  3. Primary completion20 Aug 2024
  4. Study completion30 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06871566
Sponsor's protocol ID
2024-242
Status last verified
Mar 2025
First submitted
22 Jan 2025
Last updated
12 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: This study investigates the impact of an AI-supported occupational therapy program, developed using the Model of Human Occupation (MOHO), on handwriting skills in children at risk for Developmental Coordination Disorder (DCD).

Questions about this trial

What is this clinical trial studying?

A study testing Artificial Intelligence-Supported Occupational Therapy Program in people with Occupational Therapy, run by Hacettepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Minnesota Handwriting Assessment (time frame: Two assessments, one week before the intervention and one week after the intervention was completed). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in